Absence of chronicity in infants born to immunized mothers with occult HBV infection in taiwan.

[1]  C. Yeh,et al.  Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  R. Bruno,et al.  Update of the statements on biology and clinical impact of occult hepatitis b virus infection. , 2019, Journal of hepatology.

[3]  Mei-Hwei Chang,et al.  The Impact of Universal Infant Hepatitis B Immunization on reducing the Hepatitis B Carrier Rate in Pregnant Women. , 2019, The Journal of infectious diseases.

[4]  J. Allain,et al.  Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose , 2018, Gut.

[5]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[6]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[7]  Thomas Berg,et al.  EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. , 2017, Journal of hepatology.

[8]  C. Yeh,et al.  Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody , 2016, Medicine.

[9]  H. Hsu,et al.  Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  C. Yeh,et al.  Peginterferon Is Superior to Nucleos(t)ide Analogues for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis B. , 2016, The Journal of infectious diseases.

[11]  B. McMahon,et al.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis , 2016, Hepatology.

[12]  M. Kumar,et al.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update , 2015, Hepatology International.

[13]  D. Xiao,et al.  Clinical features and outcome of acute hepatitis B in pregnancy , 2014, BMC Infectious Diseases.

[14]  M. Hudson,et al.  Hepatitis B in pregnancy , 2013, Frontline Gastroenterology.

[15]  Yali Hu,et al.  Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus , 2013, BMC Pregnancy and Childbirth.

[16]  L. Sticchi,et al.  Epidemiology of HBV S-gene mutants in the Liguria Region, Italy , 2013, Human vaccines & immunotherapeutics.

[17]  G. Raimondo,et al.  Occult HBV infection , 2012, Seminars in Immunopathology.

[18]  H. Hsu,et al.  Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. , 2012, Gastroenterology.

[19]  T. Chan,et al.  Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. , 2012, The Journal of infectious diseases.

[20]  Wei Zhao,et al.  A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. , 2011, Journal of hepatology.

[21]  C. Yeh,et al.  Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy , 2011, Hepatology.

[22]  Roger Y Dodd,et al.  Nucleic acid testing to detect HBV infection in blood donors. , 2011, The New England journal of medicine.

[23]  S. Wirth,et al.  Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen. , 2009, The Journal of infectious diseases.

[24]  Hung‐Chih Yang,et al.  Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study , 2009, Journal of viral hepatitis.

[25]  Yeou-Lih Huang,et al.  Hepatitis B virus infection among pregnant women in Taiwan: Comparison between women born in Taiwan and other southeast countries , 2008, BMC public health.

[26]  F. Zoulim,et al.  Hepatitis B virus genetic variability and evolution. , 2007, Virus research.

[27]  J. Chen,et al.  Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single‐centre randomized study , 2006, Journal of viral hepatitis.

[28]  Ding‐Shinn Chen,et al.  Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. , 2006, Journal of hepatology.

[29]  H. Hsu,et al.  Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan , 2004, Gut.

[30]  C. Coffin,et al.  Low Doses of Hepadnavirus Induce Infection of the Lymphatic System That Does Not Engage the Liver , 2004, Journal of Virology.

[31]  Hong Yang,et al.  Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies , 2003, Journal of medical virology.

[32]  S. Hasnain,et al.  Vertical transmission of hepatitis B virus despite maternal lamivudine therapy , 2002, The Lancet.

[33]  K. Goo,et al.  Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R. , 2000, The Journal of infection.

[34]  Tomasz P. Michalak.  Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model , 2000, Immunological reviews.

[35]  Tomasz P. Michalak,et al.  Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. , 1999, The Journal of clinical investigation.

[36]  N. Andrews,et al.  Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  B. Puppala,et al.  Incidence and duration of hepatitis B surface antigenemia after neonatal hepatitis B immunization. , 1994, The Journal of pediatrics.

[38]  A. Zuckerman,et al.  Vaccine-induced escape mutant of hepatitis B virus , 1990, The Lancet.